Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DNA · as of Sep 30, 2025
Ownership Breakdown
188
Institutional Holders
▲ 14 vs Q2
$437.21M
Total Inst. Value
▲ $62.01M vs Q2
65.32M
Shares Outstanding
freeFloat 73.25%
30.19M
13F Shares Held
▼ 3.16M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DNA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VIKING GLOBAL INVESTORS LP biological products, (no diagnostic substances) | 3.58M | 6.52% | 6.52% | $52.15B | Nov 14, 2025 | — held |
BLACKROCK, INC. biological products, (no diagnostic substances) | 3.42M | 6.23% | 6.23% | $49.83B | Nov 12, 2025 | ▲ 367.8K |
BAILLIE GIFFORD & CO biological products, (no diagnostic substances) | 3.24M | 5.90% | 5.90% | $47.17B | Oct 31, 2025 | ▼ 40.8K |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 2.48M | 4.52% | 4.52% | $36.17B | Nov 7, 2025 | ▲ 99.4K |
ERSTE ASSET MANAGEMENT GMBH biological products, (no diagnostic substances) | 2.20M | 4.01% | 4.01% | $29.11B | Nov 12, 2025 | ▲ 200.0K |
ANCHORAGE CAPITAL GROUP, L.L.C. biological products, (no diagnostic substances) | 1.75M | 3.18% | 3.18% | $25.46B | Nov 14, 2025 | — held |
LEGAL & GENERAL GROUP PLC biological products, (no diagnostic substances) | 1.61M | 2.93% | 2.93% | $23.46B | Nov 13, 2025 | ▲ 118.4K |
BANK OF AMERICA CORP /DE/ biological products, (no diagnostic substances) | 1.07M | 1.95% | 1.95% | $15.58B | Feb 3, 2026 | ▼ 138.6K |
FORBES J M & CO LLP biological products, (no diagnostic substances) | 1.06M | 1.93% | 1.93% | $15.46B | Oct 28, 2025 | ▼ 16.9K |
STATE STREET CORP biological products, (no diagnostic substances) | 933.8K | 1.70% | 1.70% | $13.62B | Nov 14, 2025 | ▲ 192.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
24
Increased
+1.61M shares7
New Positions
first time holders11
Decreased
−1.30M shares0
Sold Out
fully exitedNet shares change (top 50)
+306.4K
+1.61M / −1.30M
Net new holders
+20
7 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DNA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
10
Buy transactions
18
Sell transactions
0.56
Buy/Sell ratio
$2M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Coen Steven P. See remarks | May 22, 2026 | Sale | 307 | $8.33 | $2.6K | 50.7K | Form 4 ↗ |
Coen Steven P. See remarks | Apr 17, 2026 | Sale | 324 | $7.95 | $2.6K | 50.3K | Form 4 ↗ |
Coen Steven P. See remarks | Apr 13, 2026 | Sale | 33,171 | $6.41 | $212.8K | 49.8K | Form 4 ↗ |
Canton Barry 10 percent owner | Apr 10, 2026 | Sale | 124,727 | $6.43 | $802.5K | 436.4K | Form 4 ↗ |
Shetty Reshma P. See remarks | Apr 10, 2026 | Sale | 124,727 | $6.43 | $802.5K | 436.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Ginkgo Bioworks Holdings, Inc. (DNA) is primarily owned by institutional investors, who hold approximately 46.2% of total shares outstanding. Company insiders own approximately 26.75%, while retail and public investors account for the remaining 27.03%.
The largest institutional shareholder of Ginkgo Bioworks Holdings, Inc. is VIKING GLOBAL INVESTORS LP, holding approximately 3.58 million shares — equal to 6.52% of outstanding shares — as of September 30, 2025.
A total of 188 institutional investors currently hold DNA stock, with a combined institutional value of approximately $437,213,675 as of the most recent 13F filing period.
Frequently asked questions
DNA ownershipGinkgo Bioworks Holdings, Inc. (DNA) is primarily owned by institutional investors, who hold approximately 46.2% of shares. The largest shareholder is VIKING GLOBAL INVESTORS LP with a 6.52% stake. Company insiders hold 26.75%. Data sourced from SEC Form 13F as of September 30, 2025.